TickerFacts.

Ligand Pharmaceuticals Inc (LGND): Weighted Average Diluted Shares

Annual figures by period end, from SEC filings.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2020-12-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

20.29M
Year ended 2025-12-31
+6.4%
3-year compound annual growth
+3.8%
5-year compound annual growth
24.07M2009-12-31: 18.86M2010-12-31: 19.61M2011-12-31: 19.71M2012-12-31: 19.85M2013-12-31: 20.75M2014-12-31: 21.43M2015-12-31: 21.23M2016-12-31: 20.83M2017-12-31: 23.48M2018-12-31: 24.07M2019-12-31: 19.76M2020-12-31: 16.82M2021-12-31: 17.25M2022-12-31: 16.87M2023-12-31: 17.76M2024-12-31: 18.29M2025-12-31: 20.29M20.29M
2009-12-31 Weighted Average Diluted Shares (shares) 2025-12-31
Period endedWeighted Average Diluted SharesChange YoYSource filing
2025-12-3120.29M+11.0%2026-02-27, From 2025-01-01
2024-12-3118.29M+3.0%2026-02-27, From 2024-01-01
2023-12-3117.76M+5.3%2026-02-27, From 2023-01-01
2022-12-3116.87M-2.2%2025-02-28, From 2022-01-01
2021-12-3117.25M+2.5%2024-02-29, From 2021-01-01
2020-12-3116.82Mn/c2023-02-28, From 2020-01-01
2019-12-3119.76M-17.9%2022-02-28, From 2019-01-01
2018-12-3124.07M+2.5%2021-02-24, From 2018-01-01
2017-12-3123.48M+12.7%2020-02-27, From 2017-01-01
2016-12-3120.83M-1.9%2019-02-28, From 2016-01-01
2015-12-3121.23M-1.0%2018-03-01, From 2015-01-01
2014-12-3121.43M+3.3%2017-02-28, From 2014-01-01
2013-12-3120.75M+4.5%2016-11-14, From 2013-01-01
2012-12-3119.85M+0.7%2015-02-23, From 2012-01-01
2011-12-3119.71M+0.5%2014-12-12, From 2011-01-01
2010-12-3119.61M+4.0%2013-03-14, From 2010-01-01
2009-12-3118.86Mn/a2012-11-14, From 2009-01-01